Table 9 Neromuscular effects of mivacurium in paediatric patients in group A (mean ± SD, S)
From: The efficacy and safety of mivacurium in pediatric patients
Subgroups | n | Onset time | T1 5% recovery | T1 25% recovery | Recovery index | TOF ratio 90% |
|---|---|---|---|---|---|---|
Group 1 | 39 | 220 ± 73 | 327 ± 95 | 585 ± 171 | 309 ± 96 | 893 ± 268 |
Group 2 | 37 | 213 ± 71& | 308 ± 86 | 569 ± 180 | 297 ± 74 | 917 ± 230 |
Group 3 | 39 | 189 ± 64* | 347 ± 112 | 659 ± 194 | 339 ± 112 | 975 ± 231 |
Group 4 | 40 | 181 ± 60 | 346 ± 97 | 603 ± 191 | 329 ± 110 | 951 ± 262 |